Patent · US Active

Rationally designed antibodies

US8674082B2 · kind B2 · utility

0Cited by

35References

35Claims

0Family size

Assignee

Alexion Pharmaceuticals, Inc. · US

Inventors

Katherine S. Bowdish · Del Mar, US
Shana Frederickson · Solana Beach, US
Mark Renshaw · San Diego, US

Key dates

Filing date	Jul 1, 2008
Grant date	Mar 18, 2014
Priority date	—
Expiry date	Nov 8, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies or fragments thereof having at least two CDR regions replaced or fused with biologically active peptides are described. Compositions containing such antibodies or fragments thereof are useful in therapeutic and diagnostic modalities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.